nach oben

Erschienen in:

01.06.2010 | Original Paper

Community-based DOT-HAART Accompaniment in an Urban Resource-Poor Setting

verfasst von: Maribel Muñoz, Karen Finnegan, Jhon Zeladita, Adolfo Caldas, Eduardo Sanchez, Miriam Callacna, Christian Rojas, Jorge Arevalo, Jose Luis Sebastian, Cesar Bonilla, Jaime Bayona, Sonya Shin

Erschienen in: AIDS and Behavior | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

From December 2005 to April 2007, we enrolled 60 adults starting antiretroviral therapy (ART) in a health district of Lima, Peru to receive community-based accompaniment with supervised antiretroviral (CASA). Paid community health workers performed twice-daily home visits to directly observe ART and offered additional medical, social and economic support to CASA participants. We matched 60 controls from a neighboring district by age, CD4 and primary referral criteria (TB status, female, neither). Using validated instruments at baseline and 12 months (time of DOT-HAART completion) we measured depression, social support, quality of life, HIV-related stigma and self-efficacy. We compared 12 month clinical and psychosocial outcomes among CASA versus control groups. CASA participants experienced better clinical and psychosocial outcomes at 12 months, including proportion with virologic suppression, increase in social support and reduction in HIV-associated stigma.

Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., et al. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS (London, England), 14(4), 357–366. doi:10.1097/00002030-200003100-00008.

Behforouz, H. L., Kalmus, A., Scherz, C. S., Kahn, J. S., Kadakia, M. B., & Farmer, P. E. (2004). Directly observed therapy for HIV antiretroviral therapy in an urban US setting. Journal of Acquired Immune Deficiency Syndromes, 36(1), 642–645. doi:10.1097/00126334-200405010-00016.CrossRefPubMed

Berger, B. E., Ferrans, C. E., & Lashley, F. R. (2001). Measuring stigma in people with HIV: Psychometric assessment of the HIV stigma scale. Research in Nursing & Health, 24(6), 518–529. doi:10.1002/nur.10011.CrossRef

Bisson, G. P., Gaolathe, T., Gross, R., Rollins, C., Bellamy, S., Mogorosi, M., et al. (2008). Overestimates of survival after HAART: Implications for global scale-up efforts. PLoS ONE, 3(3), e1725.CrossRefPubMed

Bradley-Ewing, A., Thomson, D., Pinkston, M., & Goggin, K. J. (2008). A qualitative examination of the indirect effects of modified directly observed therapy on health behaviors other than adherence. AIDS Patient Care and STDs, 22(8), 663–668. doi:10.1089/apc.2007.0190.CrossRefPubMed

Broadhead, W. E., Gehlbach, S. H., de Gruy, F. V., & Kaplan, B. H. (1988). The Duke-UNC functional social support questionnaire. Measurement of social support in family medicine patients. Medical Care, 26(7), 709–723. doi:10.1097/00005650-198807000-00006.CrossRefPubMed

Bronfenbrenner, U. (1979). The ecology of human development: Experiments by nature and design. Cambridge: Harvard University Press.

Bukusuba, J., Kikafunda, J. K., & Whitehead, R. G. (2007). Food security status in households of people living with HIV/AIDS (PLWHA) in a Ugandan urban setting. The British Journal of Nutrition, 98(1), 211–217. doi:10.1017/S0007114507691806.CrossRefPubMed

Byakika-Tusiime, J., Oyugi, J. H., Tumwikirize, W. A., Katabira, E. T., Mugyenyi, P. N., & Bangsberg, D. R. (2003). Ability to purchase and secure stable therapy are significant predictors of non-adherence to antiretroviral therapy in Kampala, Uganda. Presented February 10–14, 2003 at the 10th Conference on Retroviruses and Opportunistic Infections (CROI), Boston, MA. Abstract #170 retrieved from http://www.retroconference.org/2003/cd/Abstract/170.htm.

Castro, A. (2005). Adherence to antiretroviral therapy: Merging the clinical and social course of AIDS. PLoS Medicine, 2(12), e338. doi:10.1371/journal.pmed.0020338.CrossRefPubMed

Castro, A., & Farmer, P. (2005). Understanding and addressing AIDS-related stigma: From anthropological theory to clinical practice in Haiti. American Journal of Public Health, 95(1), 53–59. doi:10.2105/AJPH.2003.028563.CrossRefPubMed

Chen, S. C., Yu, J. K., Harries, A. D., Bong, C. N., Kolola-Dzimadzi, R., Tok, T. S., King, C. C., & Wang, J. D. (2008). Increased mortality of male adults with AIDS related to poor compliance to antiretroviral therapy in Malawi. Tropical Medicine & International Health. doi: 10.1111/j.1365-3165.2008.02029.x.

Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., et al. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient care committee & adherence working group of the outcomes committee of the adult AIDS clinical trials group (AACTG). AIDS Care, 12(3), 255–266. doi:10.1080/09540120050042891.CrossRefPubMed

Derogatis, L. R., Lipman, R. S., Rickels, K., Uhlenhuth, E. H., & Covi, L. (1974). The hopkins symptom checklist (HSCL): A self-report symptom inventory. Behavioral Science, 19(1), 1–15. doi:10.1002/bs.3830190102.CrossRefPubMed

Farmer, P., Leandre, F., Mukherjee, J. S., Claude, M., Nevil, P., Smith-Fawzi, M. C., et al. (2001). Community-based approaches to HIV treatment in resource-poor settings. Lancet, 358(9279), 404–409. doi:10.1016/S0140-6736(01)05550-7.CrossRefPubMed

Gill, C. J., Hamer, D. H., Simon, J. L., Thea, D. M., & Sabin, L. L. (2005). No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa. AIDS (London, England), 19(12), 1243–1249. doi:10.1097/01.aids.0000180094.04652.3b.

Hardon, A. P., Akurut, D., Comoro, C., Ekezie, C., Irunde, H. F., Gerrits, T., et al. (2007). Hunger, waiting time and transport costs: Time to confront challenges to ART adherence in Africa. AIDS Care, 19(5), 658–665. doi:10.1080/09540120701244943.CrossRefPubMed

Idoko, J. A., Agbaji, O., Agaba, P., Akolo, C., Inuwa, B., Hassan, Z., et al. (2007). Direct observation therapy-highly active antiretroviral therapy in a resource-limited setting: The use of community treatment support can be effective. International Journal of STD & AIDS, 18(11), 760–763. doi:10.1258/095646207782212252.CrossRef

Kadiyala, S., & Gillespie, S. (2004). Rethinking food aid to fight AIDS. Food and Nutrition Bulletin, 25(3), 271–282.PubMed

Koenig, S. P., Leandre, F., & Farmer, P. E. (2004). Scaling-up HIV treatment programmes in resource-limited settings: The rural Haiti experience. AIDS (London, England), 18(Suppl. 3), S21–S25. doi:10.1097/00002030-200406003-00005.

Larsson, E. C., Okong, P., Thorson, A., & Ekstrom, A. M. (2007). Antiretroviral treatment of HIV in Uganda: A comparison of three different delivery models in a single hospital. Transactions of the Royal Society of Tropical Medicine and Hygiene, 101(9), 885–892. doi:10.1016/j.trstmh.2007.04.024.CrossRefPubMed

Liechty, C. A., & Bangsberg, D. R. (2003). Doubts about DOT: Antiretroviral therapy for resource-poor countries. AIDS (London, England), 17(9), 1383–1387. doi:10.1097/00002030-200306130-00013.

Mills, E. J., Nachega, J. B., Buchan, I., Orbinski, J., Attaran, A., Singh, S., et al. (2006). Adherence to antiretroviral therapy in sub-Saharan Africa and North America: A meta-analysis. Journal of the American Medical Association, 296(6), 679–690. doi:10.1001/jama.296.6.679.CrossRefPubMed

Mukherjee, J. S., Ivers, L., Leandre, F., Farmer, P., & Behforouz, H. (2006). Antiretroviral therapy in resource-poor settings: Decreasing barriers to access and promoting adherence. Journal of Acquired Immune Deficiency Syndromes, 43(Suppl. 1), S123–S126. doi:10.1097/01.qai.0000248348.25630.74.PubMed

Muyingo, S. K., Walker, A. S., Reid, A., Munderi, P., Gibb, D. M., Ssali, F., et al. (2008). Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe. Journal of Acquired Immune Deficiency Syndromes, 48(4), 468–475.CrossRefPubMed

Nachega, J. B., Knowlton, A. R., Deluca, A., Schoeman, J. H., Watkinson, L., Efron, A., et al. (2006). Treatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults. A qualitative study. Journal of Acquired Immune Deficiency Syndromes, 43(Suppl. 1), S127–S133. doi:10.1097/01.qai.0000248349.25630.3d.PubMed

Partners In Health. (2008). Partners in health 2008 annual report. Available from http://www.pih.org/inforesources/annual/PIH2008_annualreport.pdf.

Pearson, C. R., Micek, M. A., Simoni, J. M., Hoff, P. D., Matediana, E., Martin, D. P., et al. (2007). Randomized control trial of peer-delivered, modified directly observed therapy for HAART in Mozambique. Journal of Acquired Immune Deficiency Syndromes, 46(2), 238–244. doi:10.1097/QAI.0b013e318153f7ba.CrossRefPubMed

Phillips, A. N., Leen, C., Wilson, A., Anderson, J., Dunn, D., Schwenk, A., et al. (2007). Risk of extensive virological failure to the three original antiretroviral drug classes over long-term follow-up from the start of therapy in patients with HIV infection: An observational cohort study. Lancet, 370(9603), 1923–1928. doi:10.1016/S0140-6736(07)61815-7.CrossRefPubMed

Population Reference Bureau. (2006). 2006 World population data sheet. 2006, Available from http://www.prb.org/pdf06/06WorldDataSheet.pdf.

Rosen, S., Fox, M. P., & Gill, C. J. (2007). Patient retention in antiretroviral therapy programs in sub-Saharan Africa: A systematic review. PLoS Medicine, 4(10), e298. doi:10.1371/journal.pmed.0040298.CrossRefPubMed

Sarna, A., Luchters, S., Geibel, S., Chersich, M. F., Munyao, P., Kaai, S., et al. (2008). Short- and long-term efficacy of modified directly observed antiretroviral treatment in Mombasa, Kenya: A randomized trial. Journal of Acquired Immune Deficiency Syndromes, 48(5), 611–619.CrossRefPubMed

Schafer, J. (1997). Analysis of incomplete multivariate data. New York: Chapman and Hall.

Semba, R. D., Caiaffa, W. T., Graham, N. M., Cohn, S., & Vlahov, D. (1995). Vitamin A deficiency and wasting as predictors of mortality in human immunodeficiency virus-infected injection drug users. The Journal of Infectious Diseases, 171(5), 1196–1202.PubMed

Shin, S., Munoz, M., Espiritu, B., Zeladita, J., Sanchez, E., Callacna, M., et al. (2008). Psychosocial impact of poverty on antiretroviral nonadherence among HIV-TB coinfected patients in Lima, Peru. Journal of the International Association of Physicians in AIDS Care, 7(2), 74–81. doi:10.1177/1545109708315326.CrossRefPubMed

Shively, M., Smith, T., Bormann, J., & Gifford, A. (2002). Evaluating self-efficacy for HIV disease management skills. AIDS and Behavior, 6, 371–379. doi:10.1023/A:1021156914683.CrossRef

Simoni, J. M., Pearson, C. R., Pantalone, D. W., Marks, G., & Crepaz, N. (2006). Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. Journal of Acquired Immune Deficiency Syndromes, 43(Suppl. 1), S23–S35. doi:10.1097/01.qai.0000248342.05438.52.PubMed

Smith, S. R., Rublein, J. C., Marcus, C., Brock, T. P., & Chesney, M. A. (2003). A medication self-management program to improve adherence to HIV therapy regimens. Patient Education and Counseling, 50(2), 187–199.PubMed

Spacek, L. A., Shihab, H. M., Kamya, M. R., Mwesigire, D., Ronald, A., Mayanja, H., et al. (2006). Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda. Clinical Infectious Diseases, 42(2), 252–259. doi:10.1086/499044.CrossRefPubMed

Tuboi, S. H., Harrison, L. H., Sprinz, E., Albernaz, R. K., & Schechter, M. (2005). Predictors of virologic failure in HIV-1-infected patients starting highly active antiretroviral therapy in Porto Alegre, Brazil. Journal of Acquired Immune Deficiency Syndromes, 40(3), 324–328. doi:10.1097/01.qai.0000182627.28595.01.CrossRefPubMed

Van Der Ven, N. C., Weinger, K., Yi, J., Pouwer, F., Ader, H., Van Der Ploeg, H. M., et al. (2003). The confidence in diabetes self-care scale: psychometric properties of a new measure of diabetes-specific self-efficacy in Dutch and US patients with type 1 diabetes. Diabetes Care, 26(3), 713–718. doi:10.2337/diacare.26.3.713.CrossRef

van Oosterhout, J. J., Bodasing, N., Kumwenda, J. J., Nyirenda, C., Mallewa, J., Cleary, P. R., et al. (2005). Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi. Tropical Medicine & International Health, 10(5), 464–470. doi:10.1111/j.1365-3156.2005.01409.x.CrossRef

Wainberg, M. A., & Friedland, G. (1998). Public health implications of antiretroviral therapy and HIV drug resistance. Journal of the American Medical Association, 279(24), 1977–1983. doi:10.1001/jama.279.24.1977.CrossRefPubMed

Wakabi, W. (2008). Low ART adherence in Africa. The Lancet Infectious Diseases, 8(2), 94. doi:10.1016/S1473-3099(08)70010-0.CrossRefPubMed

World Health Organization. (2003). Scaling up antiretroviral therapy in resource-limited settings: Treatment guidelines for a public health approach. Available from http://www.who.int/3by5/publications/documents/arv_guidelines/en/.

Wu, A. W., Rubin, H. R., Mathews, W. C., Ware, J. E., Jr, Brysk, L. T., Hardy, W. D., et al. (1991). A health status questionnaire using 30 items from the medical outcomes study. Preliminary validation in persons with early HIV infection. Medical Care, 29(8), 786–798. doi:10.1097/00005650-199108000-00011.CrossRefPubMed

Titel: Community-based DOT-HAART Accompaniment in an Urban Resource-Poor Setting
verfasst von: Maribel Muñoz
Karen Finnegan
Jhon Zeladita
Adolfo Caldas
Eduardo Sanchez
Miriam Callacna
Christian Rojas
Jorge Arevalo
Jose Luis Sebastian
Cesar Bonilla
Jaime Bayona
Sonya Shin
Publikationsdatum: 01.06.2010
Verlag: Springer US
Erschienen in: AIDS and Behavior / Ausgabe 3/2010
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-009-9559-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2010

A Mixed Methods Evaluation of the Effect of the Protect and Respect Intervention on the Condom Use and Disclosure Practices of Women Living with HIV/AIDS

Efficacy of a Single-Session HIV Prevention Intervention for Black Women: A Group Randomized Controlled Trial

Acceptability of a Non-Woven Device for Vaginal Drug Delivery of Microbicides or Other Active Agents

Reducing HIV Risks Among Active Injection Drug and Crack Users: The Safety Counts Program

Vaginal Practices and Associations with Barrier Methods and Gel Use Among Sub-Saharan African Women Enrolled in an HIV Prevention Trial

Pilot Study Assessing HIV Vaccine Trial Readiness Among Female Sex Workers, Injection and Non-injection Drug Users, and Men Who Have Sex with Men in Spain